BACKGROUND
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996) lays down a Procedure for the establishment of a list of flavouring substances, the use of which will be authorised to the exclusion of all other substances in the EU. In application of that Regulation, a Register of flavouring substances used in or on foodstuffs in the Member States was adopted by Commission Decision 1999/217/EC (EC, 1999a) , as last amended by Commission Decision 2008/478/EC (EC, 2008) . Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are divided into 34 chemical groups. Substances within a group should have some metabolic and biological behaviour in common.
Substances which are listed in the Register are to be evaluated according to the evaluation programme laid down in Commission Regulation (EC) No 1565 /2000 (EC, 2000a , which is broadly based on the Opinion of the Scientific Committee on Food (SCF, 1999) . For the submission of data by the manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 2002b .
After the completion of the evaluation programme the positive list of flavouring substances for use in or on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 1996) .
By Commission Decision 1999/217/EC certain flavouring substances received priority in the evaluation programme since concerns about the safety of the health of consumers were expressed by some Member States. In the Register, these substances received the following remark: 3. "Substance to be given priority evaluation". Table A ). 
TERMS OF REFERENCE
The European Table 1 .
Stereoisomers
It is recognised that geometrical and optical isomers of substances may have different properties. Their flavour may be different, they may have different chemical properties resulting in possible variation of their absorption, distribution, metabolism, elimination and toxicity. Thus, information must be provided on the configuration of the flavouring substance, i.e. whether it is one of the geometrical/optical isomers, or a defined mixture of stereoisomers. The available specifications of purity will be considered in order to determine whether the safety evaluation carried out for candidate substances for which stereoisomers may exist can be applied to the material of commerce.
Flavouring substances with different configurations should have individual chemical names and codes (CAS number, FLAVIS number, etc.).
Glycyrrhizic acid .012] and glycyrrhizic acid, ammoniated .060] can exist as two stereoisomers (18-alpha-and 18-beta-isomer). The two substances have been presented without specification of the stereoisomeric composition.
Natural Occurrence in Food
Glycyrrhizic acid is a natural constituent of liquorice, isolated from the dried root of the plant Glycyrrhiza glabra L. Liquorice root contains about 2-15 % glycyrrhizic acid and liquorice blocks and extract powder about 4-25 % (Størmer et al., 1993) . Glycyrrhizic acid occurs mainly as the 18-beta-isomer but up to approximately 10 % can occur as the 18-alpha-isomer (Amagaya et al., 1985) .
Specifications
Purity criteria for the two substances have been provided by the Flavour Industry (Table 1) . 
Intake Data
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to calculate the "Maximised Survey-Derived Daily Intake" (MSDI) by assuming that the production figure only represents 60 % of the use in food due to underreporting and that 10 % of the total EU population are consumers (SCF, 1999) .
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties in the underreporting correction factor and to uncertainties in the percentage of consumers, the reliability of intake estimates on the basis of the MSDI approach is difficult to assess.
The Panel also noted that in contrast to the generally low per capita intake figures estimated on the basis of this MSDI approach, in some cases the regular consumption of products flavoured at use levels reported by the Flavour Industry in the submissions would result in much higher intakes. In such cases, the human exposure thresholds below which exposures are not considered to present a safety concern might be exceeded.
Considering that the MSDI model may underestimate the intake of flavouring substances by certain groups of consumers, the SCF recommended also taking into account the results of other intake assessments (SCF, 1999) .
One of the alternatives is the "Theoretical Added Maximum Daily Intake" (TAMDI) approach, which is calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable beverages and foods in general, with exceptional levels for particular foods. This method is regarded as a conservative estimate of the actual intake in most consumers because it is based on the assumption that the consumer regularly eats and drinks several food products containing the same flavouring substance at the upper use level.
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use levels of the flavouring substances. This modified approach is less conservative (i.e. it may underestimate the intake of consumers being loyal to products flavoured at the maximum use levels reported (EC, 2000a) . However, it is considered as a suitable tool to screen and prioritise the flavouring substances according to the need for refined intake data (EFSA, 2004a).
Estimated Daily per Capita Intake (MSDI Approach)
The Maximised Survey-Derived Daily Intake (MSDI (SCF, 1999)) data are derived from surveys on annual production volumes in Europe. These surveys were conducted in 1995 by the International Organization of the Flavour Industry, in which flavour manufacturers reported the total amount of each flavouring substance incorporated into food sold in the EU during the previous year (IOFI, 1995) . The intake approach does not consider the possible natural occurrence in food.
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is consumed by 10 % of the population 2 (Eurostat, 1998) . This is derived for candidate substances 2 EU figure 375 millions (Eurostat, 1998) . This figure relates to EU population at the time for which production data are available, and is consistent (comparable) with evaluations conducted prior to the enlargement of the EU. No production data are available for the enlarged EU.
from estimates of annual volume of production provided by Industry and incorporates a correction factor of 0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999 * The mTAMDI calculation is based on the maximum use levels as no information on the normal use levels has been provided (see Table 3 .2). Table 3 .2 shows the normal and maximum use levels for the candidate substances. (SCF, 1991) . At that time, the Committee considered it prudent that regular ingestion should not exceed 100 mg/day, while it was explicitly mentioned that this was a provisional figure. Since then, new toxicological information, including data from human volunteer studies, has become available. Although these data provide a stronger basis for the upper limit for regular ingestion of glycyrrhizinic acid of 100 mg/day, the Committee still is of the opinion that an ADI for glycyrrhizinic acid and ammonium glycyrrhizinate cannot be derived, because the new human toxicity studies are too limited (small experimental groups, short duration). The Committee considers that this upper limit for regular ingestion of 100 mg/day provides a sufficient level of protection for the majority of the population. It is noted that this upper limit includes the intake of glycyrrhizinic acid via all products, liquorice confectionery as well as glycyrrhizinic acid-or ammonium glycyrrhizinate-flavoured products. At the same time, the Committee realises that within the human population there are subgroups for which this upper limit might not offer sufficient protection."
Glycyrrhizic acid .012] and glycyrrhizic acid, ammoniated .060] have also been evaluated by the JECFA (JECFA, 2004a).
Annex II provides more detail on the outcome of these evaluations.
Conclusions
The Panel agrees with the evaluation by the SCF and emphasises the need for further information on use levels and on intakes that were requested by the SCF in its Opinion from 2003 (see Annex II). The mTAMDI of 210 mg/person/day exceeds by a factor of two the intake of 100 mg/person/day considered by the SCF to be a sufficient level of protection. Therefore, refined use levels and intake data are needed. Furthermore, the two substances have been presented without specification of the stereoisomeric composition.
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The EFSA Journal ( (JECFA, 1995; JECFA, 1996a; JECFA, 1997a; JECFA, 1999b) .
The Procedure is a stepwise approach that integrates information on intake from current uses, structure-activity relationships, metabolism and, when needed, toxicity. One of the key elements in the Procedure is the subdivision of flavourings into three structural classes (I, II, III) for which thresholds of concern (human exposure thresholds) have been specified. Exposures below these thresholds are not considered to present a safety concern.
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, which would suggest a low order of oral toxicity. Class II contains flavourings that have structural features that are less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that have structural features that permit no strong initial presumption of safety, or may even suggest significant toxicity (Cramer et al., 1978) . The thresholds of concern for these structural classes of 1800, 540 or 90 microgram/person/day, respectively, are derived from a large database containing data on subchronic and chronic animal studies (JECFA, 1996a).
In
Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further steps address the following questions:
• can the flavourings be predicted to be metabolised to innocuous products 3 (
Step 2)?
• do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)?
• are the flavourings or their metabolites endogenous 4 (Step A4)?
• does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and B4)?
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), toxicological background information available for compounds structurally related to the candidate substances is considered (supporting substances), in order to assure that these data are consistent with the results obtained after application of the Procedure.
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. Therefore, the right is reserved to use alternative approaches if data on specific flavourings warranted such actions.
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Can the substance be predicted to be metabolised to innocuous products?
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances
Do the conditions of use result in an intake greater than the threshold of concern for the structural class?
Data must be available on the substance or closely related substances to perform a safety evaluation Does a NOAEL exist for the substance which provides an adequate margin of safety under conditions of intended use, or does a NOAEL exist for structurally related substances which is high enough to accommodate any perceived difference in toxicity between the substance and the related substances?
Does a NOAEL exist for the substance which provides an adequate margin of safety under conditions of intended use, or does a NOAEL exist for structurally related substances which is high enough to accommodate any perceived difference in toxicity between the substance and the related substances?
Substance would not be expected to be of safety concern Is the substance or are its metabolites endogenous?
Additional data required
Step 1.
Step 2.
Step A3.
Step A4.
Step A5.
Step B3.
Step B4. The Committee was asked to consider if the Opinion of the Committee expressed in 1991 on glycyrrhizin is still valid in the light of additional information resulting from toxicological and clinical studies published since then on both glycyrrhizinic acid and its salts. The Committee is asked to take into account dietary exposure from all known sources, including contributions due to its natural occurrence in liquorice and through the ingestion of food products to which it is added as a flavouring substance.
The Committee is also asked to evaluate ammonium glycyrrhizinate as a chemically defined flavouring substance for the possible acceptability of its inclusion in the Community Register.
Conclusion by the SCF:
"Previously, the Committee evaluated the toxicological information for glycyrrhizinic acid and concluded that the data were inadequate to derive an ADI (SCF, 1991) . At that time, the Committee considered it prudent that regular ingestion should not exceed 100 mg/day, while it was explicitly mentioned that this was a provisional figure. Since then, new toxicological information, including data from human volunteer studies, has become available. Although these data provide a stronger basis for the upper limit for regular ingestion of glycyrrhizinic acid of 100 mg/day, the Committee still is of the opinion that an ADI for glycyrrhizinic acid and ammonium glycyrrhizinate cannot be derived, because the new human toxicity studies are too limited (small experimental groups, short duration).
The Committee considers that this upper limit for regular ingestion of 100 mg/day provides a sufficient level of protection for the majority of the population. It is noted that this upper limit includes the intake of glycyrrhizinic acid via all products, liquorice confectionery as well as glycyrrhizinic acid-or ammonium glycyrrhizinate-flavoured products.
At the same time, the Committee realises that within the human population there are subgroups for which this upper limit might not offer sufficient protection. These subgroups comprise people with decreased 11-beta-hydroxysteroid dehydrogenase-2 activity (the target enzyme of glycyrrhizinic acid, for which genetic polymorphisms resulting in reduced basal activity have been described), people with prolonged gastrointestinal transit time, and people with hypertension or electrolyterelated or water homeostasis-related medical conditions. A more extensive discussion on sensitive subgroups in the population can be found in Annex II (section on modeling "Pharmacokineticpharmacodynamic model").
The Committee notes that for ammonium glycyrrhizinate as well as for glycyrrhizinic acid, used as chemically defined flavouring substances, the Upper Use Levels in foods indicate that the Maximised Survey-Derived Intake (MSDI) exposure estimates (130 and 240 microg/person/day, respectively) may underestimate the intake for individuals who select to consume certain foods, e.g. foods flavoured at the Upper Use Levels (see Annex I).
To complete the evaluation of glycyrrhizinic acid and ammonium glycyrrhizinate as chemically defined flavouring substances, the following information needs to be provided:
• • data on occurrence of the 18-alpha isomer in the commercial product. The Committee notes that glycyrrhizinic acid and ammonium glycyrrhizinate are evaluated here irrespective of their chirality.
• for both glycyrrhizinic acid and ammonium glycyrrhizinate: more refined usage data (e.g market share data), as it seems these substances are used in many food categories, but within a given food category probably only in very few products."
JECFA evaluation (JECFA, 2005c) The JECFA Committee was asked to comment on the safety of glycyrrhizinic acid and its monoammonium salt as a natural constituent of liquorice (USA, 'licorice') and in its use as a flavouring substance in various food products.
Conclusion by the JECFA:
"The Committee concluded that the safety evaluation of glycyrrizinic acid should be based on the data from humans. It was observed that there is a sensitive subset of the population who appear to show signs of pseudohyperaldosteronism at lower exposures than those which produce effects in the general population, but the available data did not allow the Committee to adequately characterize this subgroup, and hence the data could not be used to assign an ADI. The available data suggest that an intake of 100 mg/day would be unlikely to cause adverse effects in the majority of adults. The Committee recognized that, in certain highly susceptible individuals, physiological effects could occur at intakes somewhat below this figure. The data indicate that consumers with a high intake of liquorice confectionery or herbal tea containing liquorice may have an intake of glycyrrhizinic acid of >100 mg/day." amending Directive 94/54/EC as regards the labelling of certain foods containing glycyrrhizinic acid and its ammonium salt, requiring that confectionery or beverages containing 100 mg/kg or 10 mg/l or above should be labelled "contains liquorice". Confectionery containing 4 g/kg or above should be labelled "contains liquorice. People suffering from hypertension should avoid excessive consumption". Beverages containing 50 mg/l or above or of 300 mg/l or above in the case of beverages containing more than 1.2 % by volume of alcohol should be labelled "contains liquorice. People suffering from hypertension should avoid excessive consumption" (EC, 2004b) .
